{"id":"https://openalex.org/W4282928475","doi":"https://doi.org/10.1158/1538-7445.am2022-1268","title":"Abstract 1268: Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma","display_name":"Abstract 1268: Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282928475","doi":"https://doi.org/10.1158/1538-7445.am2022-1268"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-1268","doi":"https://doi.org/10.1158/1538-7445.am2022-1268","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1268","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031665612","display_name":"Tuyen Duong Thanh Nguyen","orcid":"https://orcid.org/0000-0003-2036-5173","observed_orcids":["https://orcid.org/0000-0003-2036-5173"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen Duong Nguyen","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025296273","display_name":"Marc A. Pina","orcid":"https://orcid.org/0000-0002-5676-4048","observed_orcids":["https://orcid.org/0000-0002-5676-4048"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc A. Pina","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322938","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0003-2563-255X","observed_orcids":["https://orcid.org/0000-0003-2563-255X","https://orcid.org/0000-0003-1653-4122","https://orcid.org/0000-0002-0029-2184"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011734599","display_name":"Cansu Karaka\u015f","orcid":"https://orcid.org/0000-0003-0357-5224","observed_orcids":["https://orcid.org/0000-0003-0357-5224"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cansu Karakas","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen N. Bui","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068604697","display_name":"Osama R. Mawlawi","orcid":"https://orcid.org/0000-0003-4446-5670","observed_orcids":["https://orcid.org/0000-0003-4446-5670"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Osama Mawlawi","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050445982","display_name":"Alexander J. Lazar","orcid":"https://orcid.org/0000-0002-6395-4499","observed_orcids":["https://orcid.org/0000-0002-6395-4499"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander J. Lazar","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019756853","display_name":"Davis R. Ingram","orcid":"https://orcid.org/0000-0001-5967-1501","observed_orcids":["https://orcid.org/0000-0001-5967-1501"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davis R. Ingram","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109601916","display_name":"Peter J. Hougton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J. Hougton","raw_affiliation_strings":["2University of Texas Heath Science Center, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Texas Heath Science Center, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly K. Hunt","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["1University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"1268","last_page":"1268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/18f-flt-pet-ct","display_name":"18F-FLT PET/CT","score":0.8460000157356262},{"id":"https://openalex.org/keywords/serum-thymidine-kinase-1","display_name":"serum thymidine kinase 1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cdk4-6-inhibition","display_name":"CDK4/6 inhibition","score":0.9010000228881836},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/wee1-kinase-inhibitor","display_name":"Wee1 kinase inhibitor","score":0.7919999957084656},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9160000085830688},{"id":"https://openalex.org/keywords/retinoblastoma-pathway","display_name":"retinoblastoma pathway","score":0.9089999794960022},{"id":"https://openalex.org/keywords/cell-cycle-re-entry","display_name":"cell cycle re-entry","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6917229294776917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6712643504142761},{"id":"https://openalex.org/C2776062698","wikidata":"https://www.wikidata.org/wiki/Q21111463","display_name":"Retinoblastoma protein","level":4,"score":0.6185666918754578},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5823036432266235},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5161463022232056},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5034508109092712},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4827372431755066},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.4823143482208252},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4685099124908447},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.44365575909614563},{"id":"https://openalex.org/C2776577112","wikidata":"https://www.wikidata.org/wiki/Q500695","display_name":"Retinoblastoma","level":3,"score":0.44226503372192383},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4138070046901703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3239133059978485},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.29153287410736084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25117331743240356},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-1268","doi":"https://doi.org/10.1158/1538-7445.am2022-1268","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1268","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313554874","https://openalex.org/W1994763005","https://openalex.org/W4245876492","https://openalex.org/W2624850365","https://openalex.org/W4210670463","https://openalex.org/W2187845981","https://openalex.org/W2028799778","https://openalex.org/W2886720909","https://openalex.org/W4242996183","https://openalex.org/W2799665177"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Sarcomas":[2],"are":[3,60,461],"rare,":[4],"aggressive":[5,37,419],"tumors":[6],"that":[7,82],"make":[8],"up":[9],"a":[10,137],"higher":[11],"percentage":[12],"of":[13,24,76,86,97,108,119,125,130,147,257,275,305,312,320,380,394,467,478],"overall":[14],"cancer":[15],"mortality":[16],"in":[17,61,67,71,105,221,227,229,232,235,239,272,278,294,307,314,331,358,362,400,473],"children":[18],"and":[19,48,73,152,169,201,210,224,231,303,335,374,457],"young":[20],"adults.":[21],"Primary":[22],"management":[23],"sarcoma":[25,77,149,248,474],"patients":[26,41],"includes":[27],"surgical":[28],"resection":[29],"with":[30,36,42,162,171,192,299,365,388,402],"adjuvant":[31],"or":[32,194,322,353],"neoadjuvant":[33],"radiation/chemotherapy.":[34],"Even":[35],"multimodal":[38],"treatment":[39,191,225,242,344,384],"regimens,":[40],"high-grade":[43],"sarcomas":[44,109],"experience":[45],"suboptimal":[46],"prognosis":[47],"advanced":[49],"disease":[50],"is":[51,115],"almost":[52],"universally":[53],"fatal.":[54],"Innovative":[55],"biomarker":[56],"driven":[57],"targeted":[58,471],"therapies":[59],"urgent":[62],"need":[63],"to":[64,184,196,218,241,253,260,280,327,382,397,405,410],"improve":[65],"survival":[66],"these":[68],"patients.":[69],"Discoveries":[70],"molecular":[72],"genetic":[74],"basis":[75],"have":[78],"revealed":[79],"new":[80,141],"targets":[81],"deserve":[83],"consideration.":[84],"Inactivation":[85],"retinoblastoma":[87],"(Rb)":[88],"pathway,":[89],"which":[90],"causes":[91],"unabated":[92],"cell":[93,120,150,222,236,249,276,329,333,360,395,469],"proliferation,":[94],"through":[95,123],"overexpression":[96],"cyclin":[98],"D1":[99],"and/or":[100],"CDK4/6":[101,134,179,281],"has":[102],"been":[103],"detected":[104],"the":[106,126,186,198,254,347,383,407,479],"majority":[107],"even":[110],"when":[111],"wild-type":[112,366],"Rb":[113,131,165,174,187,266,348],"protein":[114],"expressed.":[116],"Hence,":[117],"inhibition":[118],"cycle":[121,237,277,470],"progression":[122],"reactivation":[124],"tumor":[127],"suppressor":[128],"function":[129],"by":[132,190,351],"inhibiting":[133,346],"activity":[135,256,460],"poses":[136],"potential":[138],"avenue":[139],"for":[140,417,464,482],"therapeutic":[142,318],"options.":[143],"Methods:":[144],"A":[145],"panel":[146],"4":[148,153],"lines":[151,250,334],"patient":[154],"derived":[155],"xenograft":[156],"(PDX)":[157],"models":[158,287,390],"were":[159,216,243,251],"used:":[160],"2":[161,170],"an":[163,172,342],"intact":[164],"pathway":[166,175,188,349,355],"(Rb+ve,":[167],"p16-ve)":[168],"altered":[173],"(Rb":[176],"low/-ve,":[177],"p16+ve).":[178],"inhibitor,":[180],"abemaciclib,":[181],"was":[182],"used":[183,217,399],"reactivate":[185],"followed":[189,350],"gemcitabine":[193],"WEE1-kinase-inhibitor,":[195],"target":[197],"enriched":[199],"S":[200,308,315,352],"G2/M":[202,323,354],"phase":[203,274,316],"cells":[204,268,306,313],"post-abemaciclib":[205],"removal.":[206],"18F-FLT":[207,295],"PET":[208,372,403],"imaging":[209,373,404],"serum":[211,301,375,458],"thymidine":[212],"kinase":[213],"1":[214],"(TK1)":[215],"monitor":[219],"changes":[220],"proliferation":[223,396],"response":[226,240,279,381,454],"both":[228],"vitro":[230],"vivo.":[233],"Changes":[234],"biomarkers":[238,393,463],"also":[244,369,391],"interrogated.":[245],"Results:":[246],"Rb+ve":[247,286,332],"sensitive":[252],"anti-proliferative":[255],"abemaciclib":[258],"leading":[259,326],"their":[261],"reversible":[262],"G1":[263],"arrest,":[264],"while":[265],"null":[267],"did":[269],"not":[270,289],"arrest":[271],"any":[273],"inhibition.":[282],"Following":[283],"abemciclib":[284],"removal,":[285],"(but":[288],"Rb-ve)":[290],"showed":[291],"significant":[292],"increase":[293],"biotracer":[296],"uptake":[297],"concomitant":[298],"elevated":[300],"TK1":[302,376,459],"enrichment":[304,311],"phase.":[309],"The":[310,386],"maximized":[317],"efficacy":[319],"S-phase":[321],"targeting":[324],"agents":[325],"synergistic":[328,359,465],"killing":[330,361],"PDX":[336,389],"models.":[337],"Conclusion:":[338],"Our":[339],"study":[340,387],"presents":[341],"innovative":[343],"strategy":[345],"sequentially":[356],"resulting":[357],"those":[363],"cells/tumors":[364],"Rb.":[367],"We":[368],"incorporate":[370],"real-time":[371],"as":[377],"non-invasive":[378],"indicators":[379],"strategy.":[385],"identified":[392],"be":[398],"conjunction":[401],"provide":[406],"pre-clinical":[408],"rationale":[409],"translate":[411],"our":[412],"findings":[413],"into":[414],"clinical":[415],"trials":[416],"this":[418],"disease.":[420],"Citation":[421],"Format:":[422],"Tuyen":[423,433],"Duong":[424],"Nguyen,":[425],"Marc":[426],"A.":[427],"Pina,":[428],"Yan":[429],"Wang,":[430],"Cansu":[431],"Karakas,":[432],"N.":[434],"Bui,":[435],"Osama":[436],"Mawlawi,":[437],"Alexander":[438],"J.":[439,445],"Lazar,":[440],"Davis":[441],"R.":[442],"Ingram,":[443],"Peter":[444],"Hougton,":[446],"Kelly":[447],"K.":[448],"Hunt,":[449],"Khandan":[450],"Keyomarsi.":[451],"Early":[452],"proliferative":[453],"via":[455],"[18]FLT-PET/CT":[456],"predictive":[462],"effect":[466],"sequential":[468],"therapy":[472],"[abstract].":[475],"In:":[476],"Proceedings":[477],"American":[480],"Association":[481],"Cancer":[483,494],"Research":[484],"Annual":[485],"Meeting":[486],"2022;":[487],"2022":[488],"Apr":[489],"8-13.":[490],"Philadelphia":[491],"(PA):":[492],"AACR;":[493],"Res":[495],"2022;82(12_Suppl):Abstract":[496],"nr":[497],"1268.":[498]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2022-06-16T00:00:00"}